REPLICor to present at the American Society for Microbiology General Meeting 2006
Laval, Quebec – May 5th, 2006 – REPLICor announced today that it will be a presenter at the American Society for Microbiology (ASM) General Meeting 2006 in Orlando. This poster presentation will be given by Dr Jean-Marc Juteau, Senior Vice President on May 24, 2006.
“We are happy to present at the ASM General Meeting and to report REPLICor’s latest developments in influenza drug development ” commented Dr Juteau. “ASM General Meeting is the most important microbiology conference in the World and we are proud to be one of the presenting group” he added.
About ASM General Meeting
The ASM will hold its 106th General Meeting in the Orange County Convention Center in Orlando, FL from May 21-25, 2006. The scientific program will feature nearly 300 individual colloquia, symposia, roundtable discussions, award lectures, and poster sessions. The meeting will feature approximately 2,900 scientific presentations on topics spanning the spectrum of the microbiological sciences. The ASM is the largest single life science society, composed of over 42,000 scientists and health professionals.
About REPLICor
REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV, RSV and herpes. The company’s business strategy is to enter into an alliance with a major pharmaceutical company to further develop and market its technology.
For more information:
Jean-Marc Juteau PhD, Senior V-P
REPLICor Inc.
450 688 6068